| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Catheter Ablation | 61 | 2020 | 438 | 11.35 | Why? |
| Atrial Fibrillation | 53 | 2021 | 2320 | 6.26 | Why? |
| Defibrillators, Implantable | 19 | 2019 | 624 | 4.02 | Why? |
| Pulmonary Veins | 13 | 2019 | 146 | 3.36 | Why? |
| Tachycardia, Ventricular | 12 | 2019 | 251 | 3.34 | Why? |
| Arrhythmias, Cardiac | 17 | 2020 | 2510 | 2.52 | Why? |
| Electrophysiologic Techniques, Cardiac | 11 | 2019 | 396 | 2.16 | Why? |
| Arrhythmogenic Right Ventricular Dysplasia | 5 | 2019 | 56 | 1.99 | Why? |
| Death, Sudden, Cardiac | 7 | 2019 | 522 | 1.74 | Why? |
| Heart Failure | 17 | 2020 | 6638 | 1.73 | Why? |
| Pacemaker, Artificial | 6 | 2019 | 431 | 1.56 | Why? |
| Heart Rate | 10 | 2019 | 1527 | 1.44 | Why? |
| Electric Countershock | 6 | 2018 | 284 | 1.34 | Why? |
| Heart Conduction System | 6 | 2018 | 266 | 1.29 | Why? |
| Atrial Remodeling | 3 | 2019 | 31 | 1.13 | Why? |
| Magnetic Resonance Imaging, Cine | 11 | 2019 | 669 | 1.12 | Why? |
| Cardiomyopathies | 6 | 2021 | 997 | 1.12 | Why? |
| Cardiac Resynchronization Therapy | 8 | 2019 | 191 | 1.09 | Why? |
| Stroke Volume | 9 | 2019 | 2153 | 1.06 | Why? |
| Cardiac Pacing, Artificial | 4 | 2020 | 160 | 1.05 | Why? |
| Atrial Flutter | 3 | 2019 | 143 | 0.98 | Why? |
| Anti-Arrhythmia Agents | 7 | 2019 | 325 | 0.97 | Why? |
| Action Potentials | 6 | 2019 | 368 | 0.97 | Why? |
| Workflow | 4 | 2019 | 2373 | 0.95 | Why? |
| Radiation Exposure | 3 | 2018 | 161 | 0.94 | Why? |
| Magnetic Resonance Imaging, Interventional | 2 | 2019 | 38 | 0.93 | Why? |
| Cardiomyopathy, Dilated | 3 | 2019 | 251 | 0.87 | Why? |
| Starlings | 1 | 2019 | 4 | 0.85 | Why? |
| Epicardial Mapping | 3 | 2019 | 12 | 0.83 | Why? |
| Electrocardiography, Ambulatory | 7 | 2018 | 204 | 0.80 | Why? |
| Tachycardia, Paroxysmal | 1 | 2018 | 1 | 0.78 | Why? |
| Electromagnetic Phenomena | 1 | 2018 | 21 | 0.78 | Why? |
| Sinoatrial Node | 2 | 2017 | 22 | 0.77 | Why? |
| Time and Motion Studies | 1 | 2019 | 65 | 0.76 | Why? |
| Cardiac Tamponade | 2 | 2019 | 165 | 0.76 | Why? |
| Channelopathies | 1 | 2018 | 12 | 0.74 | Why? |
| Electric Power Supplies | 1 | 2018 | 30 | 0.73 | Why? |
| Electrocardiography | 15 | 2019 | 3957 | 0.73 | Why? |
| Myocardial Ischemia | 4 | 2020 | 781 | 0.73 | Why? |
| Cardiac Conduction System Disease | 1 | 2018 | 44 | 0.72 | Why? |
| Atrial Function, Left | 1 | 2019 | 82 | 0.71 | Why? |
| Ventricular Premature Complexes | 4 | 2019 | 42 | 0.69 | Why? |
| Monitoring, Ambulatory | 2 | 2019 | 343 | 0.69 | Why? |
| Cardiology | 6 | 2018 | 2873 | 0.68 | Why? |
| Radiography, Interventional | 1 | 2018 | 158 | 0.65 | Why? |
| Recurrence | 15 | 2019 | 3675 | 0.62 | Why? |
| Treatment Outcome | 48 | 2019 | 51732 | 0.60 | Why? |
| Heart Atria | 7 | 2019 | 267 | 0.59 | Why? |
| Atrial Function, Right | 1 | 2014 | 13 | 0.58 | Why? |
| Remote Sensing Technology | 1 | 2019 | 351 | 0.57 | Why? |
| Atrial Premature Complexes | 3 | 2018 | 4 | 0.55 | Why? |
| Prosthesis-Related Infections | 1 | 2018 | 302 | 0.55 | Why? |
| Pericardial Effusion | 1 | 2018 | 312 | 0.55 | Why? |
| Cardiac Resynchronization Therapy Devices | 3 | 2019 | 64 | 0.53 | Why? |
| Ventricular Function, Left | 4 | 2018 | 1555 | 0.52 | Why? |
| Editorial Policies | 1 | 2018 | 408 | 0.48 | Why? |
| Imaging, Three-Dimensional | 6 | 2019 | 680 | 0.48 | Why? |
| Magnetic Resonance Imaging | 10 | 2019 | 6551 | 0.47 | Why? |
| Germany | 20 | 2021 | 9196 | 0.47 | Why? |
| Fluoroscopy | 4 | 2019 | 140 | 0.46 | Why? |
| Primary Prevention | 1 | 2018 | 778 | 0.45 | Why? |
| Decision Support Techniques | 1 | 2019 | 903 | 0.44 | Why? |
| Postoperative Complications | 8 | 2019 | 5861 | 0.43 | Why? |
| Gadolinium | 4 | 2019 | 318 | 0.42 | Why? |
| Defibrillators | 3 | 2019 | 144 | 0.41 | Why? |
| Cardiac Catheters | 3 | 2018 | 44 | 0.41 | Why? |
| Cardiac Surgical Procedures | 3 | 2019 | 1931 | 0.41 | Why? |
| Cardiologists | 3 | 2019 | 366 | 0.39 | Why? |
| Biomedical Research | 3 | 2019 | 5270 | 0.39 | Why? |
| Predictive Value of Tests | 11 | 2019 | 9537 | 0.38 | Why? |
| Risk Factors | 33 | 2019 | 71621 | 0.37 | Why? |
| Signal Processing, Computer-Assisted | 1 | 2010 | 193 | 0.36 | Why? |
| Atrial Natriuretic Factor | 2 | 2019 | 75 | 0.36 | Why? |
| Workload | 1 | 2019 | 1887 | 0.36 | Why? |
| Humans | 122 | 2021 | 930598 | 0.35 | Why? |
| Tachycardia, Supraventricular | 2 | 2018 | 52 | 0.35 | Why? |
| Pyridones | 3 | 2018 | 738 | 0.35 | Why? |
| Operative Time | 2 | 2019 | 450 | 0.33 | Why? |
| Contrast Media | 5 | 2019 | 1011 | 0.32 | Why? |
| Image Enhancement | 2 | 2018 | 177 | 0.32 | Why? |
| Registries | 6 | 2020 | 12327 | 0.32 | Why? |
| Risk Assessment | 16 | 2019 | 25439 | 0.32 | Why? |
| Ventricular Dysfunction, Left | 4 | 2019 | 993 | 0.31 | Why? |
| Clinical Decision-Making | 3 | 2019 | 3755 | 0.31 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.31 | Why? |
| Male | 73 | 2021 | 367725 | 0.31 | Why? |
| Time Factors | 17 | 2019 | 31397 | 0.30 | Why? |
| Female | 74 | 2021 | 380317 | 0.30 | Why? |
| Aged | 52 | 2021 | 215776 | 0.29 | Why? |
| Athletes | 1 | 2013 | 1047 | 0.29 | Why? |
| Periodicals as Topic | 1 | 2018 | 1492 | 0.28 | Why? |
| Follow-Up Studies | 14 | 2019 | 17020 | 0.27 | Why? |
| Anticoagulants | 7 | 2019 | 9563 | 0.27 | Why? |
| Cardiac Catheterization | 4 | 2019 | 882 | 0.27 | Why? |
| Acute Coronary Syndrome | 1 | 2017 | 2107 | 0.26 | Why? |
| Kaplan-Meier Estimate | 5 | 2019 | 4260 | 0.26 | Why? |
| Disease Management | 3 | 2021 | 6841 | 0.26 | Why? |
| Middle Aged | 59 | 2021 | 270681 | 0.26 | Why? |
| Pericardium | 4 | 2019 | 228 | 0.25 | Why? |
| Radiation Dosage | 2 | 2018 | 585 | 0.25 | Why? |
| Pyrazoles | 3 | 2018 | 1791 | 0.25 | Why? |
| Prospective Studies | 21 | 2019 | 43301 | 0.25 | Why? |
| Stroke | 5 | 2018 | 8839 | 0.24 | Why? |
| Factor Xa Inhibitors | 2 | 2018 | 490 | 0.24 | Why? |
| Europe | 14 | 2020 | 12702 | 0.23 | Why? |
| Heart Ventricles | 4 | 2018 | 1139 | 0.23 | Why? |
| Myocardium | 3 | 2018 | 2323 | 0.22 | Why? |
| Natriuretic Peptide, Brain | 2 | 2019 | 1215 | 0.22 | Why? |
| Multivariate Analysis | 7 | 2020 | 5440 | 0.21 | Why? |
| Equipment Safety | 2 | 2018 | 167 | 0.21 | Why? |
| Vectorcardiography | 1 | 2019 | 9 | 0.20 | Why? |
| Emergency Service, Hospital | 4 | 2021 | 14232 | 0.20 | Why? |
| Pain, Procedural | 1 | 2019 | 51 | 0.20 | Why? |
| Hospitalization | 9 | 2021 | 54280 | 0.20 | Why? |
| Stenosis, Pulmonary Vein | 1 | 2018 | 5 | 0.19 | Why? |
| Pulmonary Veno-Occlusive Disease | 1 | 2019 | 28 | 0.19 | Why? |
| Cardiac Complexes, Premature | 1 | 2018 | 1 | 0.19 | Why? |
| Professional Practice Gaps | 1 | 2018 | 41 | 0.19 | Why? |
| Microelectrodes | 1 | 2018 | 15 | 0.19 | Why? |
| Vascular Cell Adhesion Molecule-1 | 1 | 2019 | 121 | 0.19 | Why? |
| Bundle of His | 1 | 2018 | 9 | 0.19 | Why? |
| Tricuspid Valve | 1 | 2019 | 91 | 0.19 | Why? |
| Tricuspid Valve Insufficiency | 1 | 2019 | 94 | 0.18 | Why? |
| Sodium Channels | 1 | 2017 | 7 | 0.18 | Why? |
| Echocardiography, Doppler, Pulsed | 1 | 2017 | 40 | 0.18 | Why? |
| Subclavian Artery | 1 | 2017 | 21 | 0.18 | Why? |
| Magnetic Resonance Angiography | 1 | 2019 | 282 | 0.18 | Why? |
| Angioplasty, Balloon | 1 | 2018 | 66 | 0.18 | Why? |
| Drug Labeling | 1 | 2018 | 65 | 0.18 | Why? |
| Hospitals, High-Volume | 2 | 2018 | 688 | 0.18 | Why? |
| Scimitar Syndrome | 1 | 2017 | 9 | 0.18 | Why? |
| Body Surface Potential Mapping | 1 | 2017 | 20 | 0.18 | Why? |
| Disease-Free Survival | 2 | 2018 | 1654 | 0.18 | Why? |
| Vitamin K | 2 | 2018 | 263 | 0.18 | Why? |
| Needs Assessment | 2 | 2018 | 2352 | 0.18 | Why? |
| Tachycardia, Sinus | 1 | 2017 | 43 | 0.17 | Why? |
| Hospitals, Low-Volume | 1 | 2018 | 355 | 0.17 | Why? |
| Radiation Monitoring | 1 | 2017 | 25 | 0.17 | Why? |
| Prosthesis Failure | 1 | 2019 | 195 | 0.17 | Why? |
| Cryosurgery | 1 | 2018 | 57 | 0.17 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.17 | Why? |
| Prostheses and Implants | 1 | 2018 | 116 | 0.17 | Why? |
| Postoperative Period | 1 | 2019 | 651 | 0.17 | Why? |
| Guideline Adherence | 3 | 2019 | 2309 | 0.16 | Why? |
| Insurance, Health, Reimbursement | 1 | 2019 | 205 | 0.16 | Why? |
| Practice Patterns, Physicians' | 4 | 2019 | 4927 | 0.16 | Why? |
| Drug Dosage Calculations | 1 | 2018 | 243 | 0.16 | Why? |
| Intraoperative Complications | 1 | 2019 | 221 | 0.16 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.16 | Why? |
| Ventricular Fibrillation | 1 | 2017 | 126 | 0.16 | Why? |
| Secondary Prevention | 2 | 2018 | 762 | 0.16 | Why? |
| Journal Impact Factor | 1 | 2018 | 134 | 0.16 | Why? |
| Equipment Failure | 1 | 2018 | 197 | 0.16 | Why? |
| Heart Valve Prosthesis Implantation | 2 | 2019 | 552 | 0.15 | Why? |
| Aortic Valve Insufficiency | 1 | 2017 | 136 | 0.15 | Why? |
| Telemetry | 1 | 2018 | 240 | 0.15 | Why? |
| Cicatrix | 1 | 2017 | 129 | 0.15 | Why? |
| Cardiomyopathy, Hypertrophic | 1 | 2018 | 193 | 0.15 | Why? |
| Retrospective Studies | 17 | 2021 | 105322 | 0.15 | Why? |
| Hospital Costs | 1 | 2019 | 274 | 0.15 | Why? |
| Metaproterenol | 1 | 2014 | 3 | 0.15 | Why? |
| Blood Vessel Prosthesis Implantation | 1 | 2019 | 226 | 0.15 | Why? |
| Hematoma | 1 | 2019 | 305 | 0.15 | Why? |
| Neurologists | 1 | 2018 | 283 | 0.15 | Why? |
| Prosthesis Design | 4 | 2019 | 594 | 0.15 | Why? |
| Survival Rate | 6 | 2019 | 9206 | 0.15 | Why? |
| Heart Valve Diseases | 1 | 2019 | 355 | 0.14 | Why? |
| Adrenergic beta-Antagonists | 2 | 2018 | 465 | 0.14 | Why? |
| Phenotype | 4 | 2019 | 4037 | 0.14 | Why? |
| Propranolol | 1 | 2014 | 36 | 0.14 | Why? |
| Diffusion of Innovation | 1 | 2018 | 440 | 0.14 | Why? |
| Age Factors | 7 | 2019 | 21039 | 0.13 | Why? |
| Societies, Medical | 4 | 2019 | 6907 | 0.13 | Why? |
| Mitral Valve Insufficiency | 1 | 2018 | 302 | 0.13 | Why? |
| Adipose Tissue | 1 | 2019 | 612 | 0.13 | Why? |
| Rivaroxaban | 1 | 2017 | 467 | 0.13 | Why? |
| Cardiology Service, Hospital | 1 | 2020 | 602 | 0.13 | Why? |
| Health Care Costs | 2 | 2019 | 1007 | 0.13 | Why? |
| Ischemic Attack, Transient | 1 | 2017 | 439 | 0.13 | Why? |
| Amiodarone | 1 | 2014 | 110 | 0.13 | Why? |
| Cognition | 2 | 2019 | 1394 | 0.13 | Why? |
| Terminology as Topic | 1 | 2018 | 546 | 0.13 | Why? |
| Sex Factors | 3 | 2019 | 11014 | 0.12 | Why? |
| Multimodal Imaging | 1 | 2017 | 534 | 0.12 | Why? |
| Hospitals | 6 | 2021 | 11793 | 0.12 | Why? |
| Adrenergic beta-2 Receptor Agonists | 1 | 2014 | 142 | 0.12 | Why? |
| Genetic Predisposition to Disease | 2 | 2018 | 4027 | 0.12 | Why? |
| Echocardiography, Transesophageal | 4 | 2018 | 447 | 0.12 | Why? |
| Glomerular Filtration Rate | 1 | 2019 | 1262 | 0.12 | Why? |
| Prognosis | 8 | 2019 | 32490 | 0.12 | Why? |
| Heart Injuries | 1 | 2019 | 608 | 0.12 | Why? |
| Pilot Projects | 3 | 2019 | 5182 | 0.12 | Why? |
| Echocardiography | 4 | 2018 | 3661 | 0.11 | Why? |
| ST Elevation Myocardial Infarction | 2 | 2018 | 3051 | 0.11 | Why? |
| General Practitioners | 1 | 2018 | 568 | 0.11 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2018 | 665 | 0.11 | Why? |
| Sick Sinus Syndrome | 1 | 2010 | 14 | 0.11 | Why? |
| Health Expenditures | 1 | 2019 | 904 | 0.11 | Why? |
| Metabolic Syndrome | 1 | 2018 | 810 | 0.11 | Why? |
| Safety | 1 | 2018 | 1583 | 0.10 | Why? |
| Radiologists | 1 | 2017 | 873 | 0.10 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.10 | Why? |
| Multicenter Studies as Topic | 1 | 2017 | 2437 | 0.10 | Why? |
| ROC Curve | 2 | 2019 | 6024 | 0.10 | Why? |
| Vascular Diseases | 1 | 2019 | 846 | 0.10 | Why? |
| Genome-Wide Association Study | 1 | 2017 | 1648 | 0.10 | Why? |
| Reproducibility of Results | 4 | 2019 | 11304 | 0.10 | Why? |
| Image Processing, Computer-Assisted | 1 | 2018 | 1383 | 0.10 | Why? |
| Practice Guidelines as Topic | 6 | 2019 | 15421 | 0.10 | Why? |
| Models, Cardiovascular | 1 | 2010 | 153 | 0.10 | Why? |
| Patient Selection | 3 | 2018 | 4560 | 0.10 | Why? |
| Aspirin | 1 | 2017 | 1043 | 0.10 | Why? |
| Swine | 2 | 2017 | 3352 | 0.10 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.09 | Why? |
| Heart-Assist Devices | 1 | 2017 | 812 | 0.09 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2019 | 10649 | 0.09 | Why? |
| Adult | 22 | 2019 | 244371 | 0.09 | Why? |
| Mental Disorders | 2 | 2021 | 6742 | 0.09 | Why? |
| Peptide Fragments | 1 | 2019 | 2075 | 0.09 | Why? |
| Torsades de Pointes | 1 | 2010 | 229 | 0.09 | Why? |
| Outpatients | 1 | 2021 | 3417 | 0.09 | Why? |
| Cardiovascular Diseases | 3 | 2021 | 11497 | 0.09 | Why? |
| Heart | 1 | 2017 | 1791 | 0.09 | Why? |
| Kidney | 2 | 2019 | 3648 | 0.08 | Why? |
| Health Services Needs and Demand | 2 | 2021 | 3419 | 0.08 | Why? |
| Odds Ratio | 4 | 2021 | 5861 | 0.08 | Why? |
| Endovascular Procedures | 1 | 2017 | 1302 | 0.08 | Why? |
| Healthcare Disparities | 3 | 2019 | 3893 | 0.08 | Why? |
| Patient Admission | 2 | 2021 | 5250 | 0.08 | Why? |
| Normal Distribution | 2 | 2018 | 64 | 0.08 | Why? |
| Monitoring, Intraoperative | 2 | 2018 | 140 | 0.08 | Why? |
| Administration, Oral | 3 | 2018 | 2340 | 0.08 | Why? |
| Animals | 5 | 2019 | 78931 | 0.08 | Why? |
| Disease Progression | 3 | 2019 | 13580 | 0.07 | Why? |
| Thromboembolism | 1 | 2018 | 2101 | 0.07 | Why? |
| Chi-Square Distribution | 2 | 2018 | 961 | 0.07 | Why? |
| Health Status | 1 | 2018 | 3259 | 0.07 | Why? |
| Blood Coagulation | 1 | 2018 | 2768 | 0.07 | Why? |
| Aged, 80 and over | 10 | 2019 | 88759 | 0.07 | Why? |
| Myocarditis | 2 | 2017 | 2731 | 0.07 | Why? |
| Education, Medical, Graduate | 1 | 2018 | 2082 | 0.07 | Why? |
| Coronary Artery Disease | 1 | 2019 | 2570 | 0.07 | Why? |
| Esophagus | 1 | 2006 | 139 | 0.07 | Why? |
| Comorbidity | 5 | 2021 | 34796 | 0.07 | Why? |
| Nomograms | 1 | 2010 | 790 | 0.07 | Why? |
| Databases, Factual | 4 | 2021 | 6248 | 0.07 | Why? |
| Recovery of Function | 3 | 2019 | 2461 | 0.07 | Why? |
| Ambulatory Care | 1 | 2021 | 4947 | 0.06 | Why? |
| Fibrosis | 2 | 2017 | 800 | 0.06 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.06 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.06 | Why? |
| Prevalence | 4 | 2018 | 25773 | 0.06 | Why? |
| Equipment Design | 3 | 2018 | 3095 | 0.06 | Why? |
| Exercise Test | 2 | 2019 | 911 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2018 | 3361 | 0.06 | Why? |
| Statistics, Nonparametric | 2 | 2017 | 1008 | 0.06 | Why? |
| Aging | 1 | 2018 | 3581 | 0.06 | Why? |
| Proportional Hazards Models | 3 | 2019 | 6543 | 0.06 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.06 | Why? |
| Endoscopy | 1 | 2012 | 1564 | 0.06 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.05 | Why? |
| Multi-Institutional Systems | 1 | 2020 | 97 | 0.05 | Why? |
| Morbidity | 2 | 2018 | 1426 | 0.05 | Why? |
| Biomarkers | 3 | 2019 | 23361 | 0.05 | Why? |
| Heart Diseases | 1 | 2018 | 3503 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Polytetrafluoroethylene | 1 | 2019 | 19 | 0.05 | Why? |
| Incidence | 5 | 2021 | 25622 | 0.05 | Why? |
| Coronary Angiography | 2 | 2019 | 2275 | 0.05 | Why? |
| Gadolinium DTPA | 1 | 2018 | 45 | 0.05 | Why? |
| Heart Auscultation | 1 | 2018 | 6 | 0.05 | Why? |
| Exercise | 1 | 2019 | 6771 | 0.05 | Why? |
| Time | 1 | 2021 | 631 | 0.05 | Why? |
| Heterografts | 1 | 2019 | 203 | 0.05 | Why? |
| Vascular Patency | 1 | 2018 | 96 | 0.05 | Why? |
| Catheters | 1 | 2018 | 93 | 0.05 | Why? |
| Angiography | 1 | 2019 | 301 | 0.05 | Why? |
| Preoperative Care | 2 | 2019 | 1515 | 0.04 | Why? |
| Organ Size | 1 | 2019 | 384 | 0.04 | Why? |
| Occupational Exposure | 1 | 2017 | 4742 | 0.04 | Why? |
| Blood Vessel Prosthesis | 1 | 2019 | 115 | 0.04 | Why? |
| Severity of Illness Index | 7 | 2020 | 48226 | 0.04 | Why? |
| Phantoms, Imaging | 1 | 2018 | 146 | 0.04 | Why? |
| Vena Cava, Superior | 1 | 2017 | 30 | 0.04 | Why? |
| Organizational Objectives | 1 | 2019 | 180 | 0.04 | Why? |
| Diastole | 1 | 2017 | 168 | 0.04 | Why? |
| Bioprosthesis | 1 | 2019 | 126 | 0.04 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2021 | 10697 | 0.04 | Why? |
| Myocardial Perfusion Imaging | 1 | 2019 | 218 | 0.04 | Why? |
| Steam | 1 | 2018 | 132 | 0.04 | Why? |
| Sus scrofa | 1 | 2018 | 205 | 0.04 | Why? |
| Cardiac Electrophysiology | 1 | 2018 | 239 | 0.04 | Why? |
| Cohort Studies | 5 | 2019 | 36005 | 0.04 | Why? |
| Endocardium | 1 | 2017 | 90 | 0.04 | Why? |
| Myocardial Contraction | 1 | 2018 | 123 | 0.04 | Why? |
| Systole | 1 | 2017 | 252 | 0.04 | Why? |
| Patient Health Questionnaire | 1 | 2019 | 625 | 0.04 | Why? |
| Intraoperative Care | 1 | 2018 | 238 | 0.04 | Why? |
| Evaluation Studies as Topic | 1 | 2018 | 391 | 0.04 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.04 | Why? |
| Metals | 1 | 2018 | 182 | 0.04 | Why? |
| Cost Savings | 1 | 2019 | 296 | 0.04 | Why? |
| Myocardial Revascularization | 1 | 2018 | 267 | 0.04 | Why? |
| Artifacts | 1 | 2018 | 250 | 0.04 | Why? |
| Surgery, Computer-Assisted | 1 | 2018 | 183 | 0.04 | Why? |
| Observer Variation | 1 | 2018 | 622 | 0.04 | Why? |
| Electric Impedance | 1 | 2018 | 283 | 0.04 | Why? |
| Models, Economic | 1 | 2019 | 316 | 0.04 | Why? |
| Medical Overuse | 1 | 2018 | 146 | 0.04 | Why? |
| Adenosine | 1 | 2019 | 509 | 0.04 | Why? |
| Device Removal | 1 | 2017 | 221 | 0.04 | Why? |
| Chest Pain | 1 | 2019 | 578 | 0.04 | Why? |
| Analysis of Variance | 1 | 2018 | 950 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Confidence Intervals | 1 | 2017 | 744 | 0.04 | Why? |
| Models, Animal | 1 | 2018 | 788 | 0.04 | Why? |
| Inappropriate Prescribing | 1 | 2018 | 284 | 0.03 | Why? |
| Walk Test | 1 | 2017 | 461 | 0.03 | Why? |
| Physicians, Primary Care | 1 | 2018 | 298 | 0.03 | Why? |
| Cardiac Imaging Techniques | 1 | 2017 | 357 | 0.03 | Why? |
| Mitral Valve | 1 | 2018 | 342 | 0.03 | Why? |
| Internationality | 2 | 2017 | 3297 | 0.03 | Why? |
| European Union | 1 | 2018 | 565 | 0.03 | Why? |
| Research Design | 3 | 2017 | 5830 | 0.03 | Why? |
| Ventricular Remodeling | 1 | 2017 | 349 | 0.03 | Why? |
| Consensus | 2 | 2018 | 6345 | 0.03 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.03 | Why? |
| Exercise Tolerance | 1 | 2017 | 634 | 0.03 | Why? |
| Drug-Eluting Stents | 1 | 2018 | 562 | 0.03 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.03 | Why? |
| Linear Models | 1 | 2018 | 1914 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
| Delayed Diagnosis | 1 | 2021 | 1529 | 0.03 | Why? |
| Patient Readmission | 1 | 2020 | 1543 | 0.03 | Why? |
| Hemodynamics | 1 | 2019 | 1562 | 0.03 | Why? |
| Aortic Valve | 1 | 2017 | 664 | 0.03 | Why? |
| Stents | 1 | 2018 | 916 | 0.03 | Why? |
| Sex Distribution | 1 | 2018 | 2083 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.03 | Why? |
| Length of Stay | 2 | 2019 | 11042 | 0.02 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.02 | Why? |
| Drug Monitoring | 1 | 2017 | 1408 | 0.02 | Why? |
| Health Care Surveys | 1 | 2019 | 2942 | 0.02 | Why? |
| Intracranial Hemorrhages | 1 | 2017 | 1170 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2019 | 2259 | 0.02 | Why? |
| Single-Blind Method | 1 | 2012 | 1283 | 0.02 | Why? |
| Israel | 1 | 2017 | 2751 | 0.02 | Why? |
| Age Distribution | 1 | 2018 | 3567 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Netherlands | 1 | 2017 | 3533 | 0.02 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2017 | 1671 | 0.02 | Why? |
| Postoperative Care | 1 | 2012 | 755 | 0.02 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.02 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.02 | Why? |
| Long-Term Care | 1 | 2018 | 2047 | 0.02 | Why? |
| Sinus of Valsalva | 1 | 2005 | 12 | 0.02 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.02 | Why? |
| Electronic Health Records | 1 | 2018 | 3492 | 0.02 | Why? |
| Hemorrhage | 1 | 2017 | 3013 | 0.02 | Why? |
| Global Health | 2 | 2019 | 13911 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Clinical Competence | 1 | 2018 | 3263 | 0.02 | Why? |
| Referral and Consultation | 1 | 2019 | 4816 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2019 | 5883 | 0.01 | Why? |
| Sweden | 1 | 2009 | 1969 | 0.01 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2019 | 22971 | 0.01 | Why? |
| Pulmonary Artery | 1 | 2005 | 803 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2012 | 9893 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Infant | 1 | 2018 | 30274 | 0.01 | Why? |
| Adolescent | 2 | 2018 | 86841 | 0.01 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.01 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2006 | 25144 | 0.00 | Why? |